Convexity Labs

CGBD

Convexity Analyst · CGBD
Holdmedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: CGBD (Carlyle Secured Lending, Inc.) Date: 2026-06-13 Current Price: $10.95

1. Structural Readiness

State: Context-Only Conservative Entry:Breakout Level:Extension:ATR Current: 2.3% (Sub-threshold)

Analysis:

2. Thesis Layer

Thesis Classification: TACTICAL / SETUP-LED Secular Exposure: None Named

At this date, CGBD is not anchored to a named macro or secular thesis (e.g., "Rising Rates Beneficiary" or "AI Infrastructure Credit"). The investment case is strictly tactical and setup-led. The conviction must be derived entirely from the quality of the business fundamentals and the eventual formation of a technical structure, rather than a pre-existing macro narrative. There is no evidence of a specific "narrative" driving the price action as of 2026-06-13; the name is being judged on its operational metrics and the potential for a technical breakout once the structural setup forms.

3. The Business

Company Profile: Carlyle Secured Lending, Inc. (CGBD) operates as a Business Development Company (BDC) focused on the U.S. middle market. Its core strategy involves assembling a portfolio of secured debt investments in U.S. middle-market companies, typically defined as those with EBITDA of approximately $25.0 million or greater, often supported by financial sponsors (private equity firms).

Business Model & Operations (as of 2026-06-13):

  • Investment Strategy: The firm provides a diverse array of financing, including first and second lien senior secured loans, unsecured debt, mezzanine debt, and equity stakes. The portfolio is heavily weighted toward first lien debt, which constituted 83.4% of the portfolio as of March 31, 2026 (Source: E10).
  • Portfolio Composition: As of March 31, 2026, the portfolio comprised 171 companies across more than 25 industries. A significant majority of deals are in "old economy" sectors, including industrials, aerospace and defense, health care, and consumer products (Source: E6, E7).
  • Originations & Growth: In the quarter ended March 31, 2026, the firm funded $217 million of investments and closed over $1.2 billion of new and incremental commitments at the platform level (Source: E1). Management expects portfolio growth in the second quarter of 2026 due to a strong visible pipeline and fewer expected repayments (Source: E3).
  • Credit Quality: Management noted that spreads for new investments widened by nearly 50 basis points on average compared to the prior quarter, with first lien deals being "over a quarter turn less levered at origination" (Source: E2).
  • Capital Markets Activity: The firm expects to price and close two additional CLOs in 2026, aiming for a cadence of four CLO issuances per year to ensure vintage diversification (Source: E5).
  • Dividend Policy: Management reset the base dividend to $0.35 per share for the second quarter of 2026 (down from $0.40), equating to a dividend yield on NAV of 8.8% (Source: E8). Management expects to grow the dividend as the joint venture (JV) ramps in coming quarters (Source: E4).

4. Archetype and Conviction

Archetype: Defensive Operator / Income Generator Valuation Context: The financial spine indicates a forward consensus EPS of $1.38 for FY1 and $1.43 for FY2 (Source: E23). With a current price of $10.95, the stock trades at approximately 7.9x FY1 EPS. The dividend yield on NAV is explicitly stated at 8.8% (Source: E8).

Conviction Stack:

  • Thesis Strength: Low (No named macro thesis; purely tactical).
  • Evidence Quality: High. The evidence base is robust, featuring specific earnings transcript quotes and SEC filing data from May 2026 regarding originations, portfolio composition, and credit metrics.
  • Setup Readiness: Low. The ATR of 2.3% is sub-threshold, and no coil structure is identified.
  • Rerating Potential: Dependent on the successful ramping of the JV and the execution of the CLO issuance plan.

Assessment:

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate:

  • A significant deterioration in the credit quality of the "old economy" portfolio (industrials, aerospace) would threaten the dividend sustainability.
  • Failure to execute the planned CLO issuances or the JV ramp could stall the expected dividend growth.

What Would Strengthen:

  • Confirmation of the "strong visible pipeline" mentioned in E3 leading to actual portfolio growth in Q2.
  • Successful pricing and closing of the two additional CLOs expected in 2026 (Source: E5).
  • A technical breakout above a defined resistance level with expanding volume (currently missing).

Gaps in Evidence:

  • NAV vs. Market Price: While the dividend yield on NAV is given (8.8%), the specific NAV per share is not explicitly stated in the provided evidence, making a precise discount/premium calculation impossible.
  • JV Details: The "JV" mentioned in E4 and E5 is referenced as a driver for future growth, but the specific structure, timeline, or current status of this joint venture is not detailed in the provided text.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Strong originations ($1.2B closed) and high first-lien concentration (83.4%); Dividend yield on NAV of 8.8% provides income floor; Management guidance for portfolio growth in Q2. Expected path: Management expects portfolio growth and dividend growth as the JV ramps; price likely to remain range-bound until a technical breakout or fundamental catalyst (CLO closing) occurs. Expected horizon: 3-6 months for structural clarity or fundamental catalysts to materialize.

Loading chart...
Exhibit 1: CGBD daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for CGBD.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for CGBD.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: